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Abstract
Background: Considerable variation in the prevalence of childhood asthma and its symptoms (wheezing)
has been observed in previous studies and there is evidence that the prevalence has been increasing over
time.
Methods:  We have systematically reviewed the reported prevalence and time trends of wheezing
symptoms among children, worldwide and within the same country over time. All studies comprising more
than 1000 persons and meeting certain other quality criteria published over a 16-year period, between
January 1990 and December 2005, are reported and a comparison of ISAAC (International Study of
Asthma and Allergies in Childhood) and non-ISAAC studies is made, in part as a way of expanding the
power to examine time trends (the older studies tend to be non-ISAAC), but also to examine possible
methodological differences between ISAAC and non-ISAAC questions.
Results: A wide range of current prevalence of wheeze was observed between and within countries over
time. The UK had the highest recorded prevalence of 32.2% in children aged 13–14 in 1994–5 and Ethiopia
had the lowest prevalence, 1.7% in children aged 10–19 in 1996. All studies in Australia and the UK were
compared using multiple logistic regression. ISAAC phase I and III studies reported significantly higher
prevalence of current wheeze (OR = 1.638) compared with non-ISAAC studies, after adjusting for various
other factors (country, survey year, age of child, parental vs child response to the survey). Australia
showed a significantly higher prevalence of current wheezing (OR = 1.343) compared with the UK, there
was a significant increase in the prevalence odds ratio per survey year (2.5% per year), a significant
decrease per age of child (0.7% per year), and a significantly higher response in current wheezing if the
response was self-completed by the child (OR = 1.290). These factors, when explored separately for
ISAAC and non-ISAAC studies, showed very different results. In ISAAC studies, or non-ISAAC studies
using ISAAC questions, there was a significant decrease in current wheezing prevalence over time (2.5%
per year). In non-ISAAC studies, which tend to cover an earlier period, there was a significant increase
(2.6% per year) in current wheezing prevalence over time. This is very likely to be a result of prevalence
of wheezing increasing from the 1970s up to the early 1990s, but decreasing since then.
Conclusion:  The UK has the highest recorded prevalence of wheezing and Ethiopia the lowest.
Prevalence of wheezing in Australia and the UK has increased from the 1970s up to the early 1990s, but
decreased since then and ISAAC studies report significantly higher prevalences than non-ISAAC studies.
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Background
Considerable variation in the prevalence of childhood
asthma and its symptoms (in particular, wheezing) has
been observed in previous studies and there is evidence
that the prevalence has been increasing over time. These
differences may, in part, be due to geographical variations
and due to methodological problems in defining asthma
symptoms.
There is a multiplicity of endpoints used to define and
diagnose asthma in an individual. For example, diagnosis
is often based on a detailed medical history, including
family health history, combined with examination of the
upper and lower respiratory tract [1]. Typically, this infor-
mation is combined with information from laboratory
tests. However, diagnostic criteria often differ between
doctors in the same locality as well as between countries,
and access to health care in different countries can also
have an influence on the reported prevalence of doctor-
diagnosed asthma.
Epidemiological studies have used different methods of
measuring asthma prevalence and its symptoms in sur-
veys. Questionnaires are administered, and depending on
the wording of the questions asked, there has been varia-
tion in the symptoms elicited. The symptoms may not be
present on a particular day, so a one-year period preva-
lence is often used in epidemiological studies to allow for
seasonal variation.
In self-reported asthma, questions are usually asked about
wheezing, chest tightness, breathlessness and coughing,
but studies have shown that wheezing is the most impor-
tant symptom for the identification of asthma in epidemi-
ological studies [1,2]. Some studies have shown that self-
reported wheeze has reasonably good specificity and sen-
sitivity for bronchial hyper-responsiveness both in chil-
dren and adults [3-5]. Wheeze is rarely a symptom of
other diseases, in particular emphysema or chronic bron-
chitis, which are rare in children, but it is very often indic-
ative of acute viral infection, which is common in this age
group [6].
Doctor diagnosed asthma has been shown to have a lower
prevalence than the actual symptoms reported by the indi-
vidual [1,7-9]. Until the early 1990's, there was no stand-
ardized method of comparing asthma prevalence between
countries. Only a small number of studies had used com-
mon protocols [9-13]. In 1991 the International Study of
Asthma and Allergies in Childhood (ISAAC) was set up to
achieve uniform diagnostic criteria [14]. Their first world-
wide epidemiological study, Phase I, was carried out in
1994–95. It included 56 countries and reported the prev-
alence of asthma symptoms in 6–7 year old children and
in 13–14 year old adolescents [15]. The Phase III study
used the same research design as Phase I, but was carried
out in 2002–03 [16]. The Phase II study comprised a
much more detailed investigation of possible correlates of
childhood asthma, in particular eczema, and in contrast
to ISAAC Phase I and III used 9–11 year old children
[17,18]. The ISAAC questionnaire is now widely used to
assess self-diagnosed asthma by asking about the symp-
toms [19].
This review has been carried out to assess and summarise
the extent of the literature published on wheezing symp-
toms in children, which includes not only ISAAC but also
all non-ISAAC studies that fulfilled specific quality crite-
ria. There are many studies published which are not
ISAAC and it is worthwhile to combine the published lit-
erature in a review such as this. We report the prevalence
and time trends of current symptoms of childhood wheez-
ing in the past 12 months in all studies, worldwide and
within the same region over different time periods, and
compare the results of ISAAC and non-ISAAC studies. A
particular focus of parts of the analysis are studies in the
UK and Australia, because of the large number of studies
carried out in these two countries – we examine in some
detail differences in time trends of wheeze between the
two countries. As we shall see, there are distinct, and per-
haps surprising, differences between these two developed
countries. In what follows one should note the distinction
between the underlying medical condition, "asthma" and
its principal symptom, "wheezing"; however, as above, we
are referring in all cases to studies of wheezing symptoms.
Methods
Studies included in this systematic review had to satisfy
the following requirements:
1. listed in Medline or Embase databases;
2. published in the period January 1990 to December
2005;
3. using the keywords: 'prevalence' AND
'asthma OR wheeze OR wheezing' AND
'child OR children OR adolescent';
4. full journal articles (rather than abstracts) published in
English;
5. epidemiological studies of sample size greater than
1000;
6. prevalence of 'current wheezing' is reported.Environmental Health 2008, 7:57 http://www.ehjournal.net/content/7/1/57
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In most epidemiological studies of the prevalence of
asthma symptoms, two main types of questions are used.
(i) 'Current' asthma/wheezing, which is normally a period
prevalence, and where the question asked is often of the
form "Have you had asthma/wheezing in the past 12
months?"
(ii) 'Lifetime' asthma/wheezing, in which the question is
often "Have you ever had asthma/wheezing at anytime in
the past?"
Estimates of current prevalence are likely to be more reli-
able, although Kuehni et al have shown that retrospective
recall of wheeze at age 8–13 years is a valid proxy measure
for lifetime prevalence of wheeze [20]. Questions which
are similar to: "In the past 12 months, has the child had
wheezing/whistling in the chest?" (from ISAAC question-
naire), i.e. current wheezing, will be used in this review
(see footnote 'Prevalence' in Additional File 1). Examples
of questions that were asked, and could not be included
in this review were: doctor diagnosed asthma (as asthma
diagnosis varies by countries); self-reported asthma or
asthma attacks in the last 12 months; wheeze ever or occa-
sional wheeze ever (for which there could be recall prob-
lems).
A minimum sample size of 1000 was used, as recom-
mended by the ISAAC Steering Committee for small pop-
ulations [15], to obtain good estimates of wheezing
prevalence.
For each selected article in this review, the following infor-
mation was extracted and given in Additional Files 1, 2, 3,
4, 5:
Country Country in which the study was carried out
Reference Reference number of the journal article
Survey year Year in which the survey was carried out, if
reported, otherwise the year prior to publication year
Area City/region
N (Response rate) Number of questionnaires returned and
response rate
Age (years) Age range of children sampled (years)
Ascertainment Method of ascertainment of wheeze (P =
Parental-report, S = Self-report)
Prevalence % The percentage of children (boys and girls
combined) who responded 'Yes' to the particular wheez-
ing question (see footnote in Additional File 1 for differ-
ent types of questions) out of the total number of children
who answered that question, and type of question asked
95% CI 95% confidence interval for the prevalence (if
unreported in the article then CI for a single proportion
was calculated based on the prevalence and sample size)
In the ISAAC questionnaire, limited agreement has been
shown between the written and video questionnaires of
symptoms of asthma; the video questionnaire giving
lower prevalence rates in 13–14 year old adolescents in
two Canadian communities [21]. In the studies reported
here, if both methods are used then the written question-
naire results were reported.
To investigate time trends within Australia and the UK,
multiple logistic regression models were fitted using
wheezing prevalence as the outcome variable. The stand-
ard log-linear logistic model was used, so that the proba-
bility of an individual in stratum i  being affected by
wheeze was assumed to be:
and where (zji)j are the set of variables (country, year,
ISAAC vs non-ISAAC study etc) associated with that stra-
tum. The models were fitted via binomial maximum like-
lihood using SPSS and the odds ratios, that is to say the
quantities, exp [αi], and 95% profile-likelihood confi-
dence intervals are reported [22]. For studies where the
year of survey was not reported in the article for Australia
and the UK, the year prior to the year of publication was
used as survey year in the logistic regression analysis.
Results
From the literature search, 2,839 abstracts were listed in
Medline, and 2,844 in Embase, from which 712 full arti-
cles were selected for further investigation after reviewing
the abstracts. From these, 180 satisfied the above criteria.
Some articles had referred to the same data set, thus there
were 127 distinct studies reported in this review.
Prevalence
Additional Files 1, 2, 3, 4, 5 give the prevalence of current
wheezing in children for the five continents. There is a
very wide range of current prevalence of wheeze between
and within different countries. The UK reported the high-
est prevalence of current wheeze in the world, 32.2%, in
children aged 13–14 in 1994–1995 [15]. Ethiopia had the
lowest prevalence, 1.7% in children aged 10–19 in 1996
[23].
Pi
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i
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Studies in North and South America
Additional File 1 shows the studies carried out in North
and South America; among these countries the USA had
the largest number of published studies. A nationwide
survey in the USA between 1988–1994 showed that the
current prevalence of wheezing amongst 2–3 year olds
was 26.4% and amongst 9–11 year olds was 13.4% [24].
The highest prevalence rates were recorded in North Caro-
lina, 26.1% in children aged 13–14 in 1999–2000 [25].
In the rest of North America, Canada had recorded sub-
stantially higher prevalence rates in children aged 13–14
(30.6% in Hamilton and 24.0% in Saskatoon) than in
children aged 6–7 (20.1% in Hamilton and 14.1% in Sas-
katoon) [15]. The study in Montreal [26] in 6–12 year
olds showed very low prevalence of current wheezing,
5.1%; it has been shown that this is likely to be due to
unsatisfactory translation of the term wheezing into
French, in another study carried out in Quebec [27]. Mex-
ico had the lowest prevalence of current wheezing (<
10%) [15,28]. In Central America, both Costa Rica and
Panama showed very high prevalence of wheezing (32.1%
and 23.5% respectively) in 6–7 year old children in 1995
[15].
In studies carried out in South America high prevalence
rates were observed in Chile [12] (17.2% in 15-yr-olds to
26.2% in 7-yr-olds), as early as 1990. In Brazil, the ISAAC
Phase I study [15] carried out in 1994–95 and the same
ISAAC questionnaire methodology used in a study
amongst 6–7 and 13–14 year olds carried out in 1999 in
one of the same centres as the Phase I study [29], both
showed higher prevalence of current wheezing than in the
non-ISAAC study carried out in 1994, using the same
ISAAC methodology in two non-ISAAC centres (iron-
mining cities in a mountainous region).
Studies in Europe
Of the five continental groups Europe had the largest
number of published studies overall (Additional File 2).
The UK had the highest prevalence, of 32.2% in 1994–5,
in the ISAAC Phase I study of 35,485 adolescents [15,30].
Low prevalence rates, of less than 10%, were observed in
Albania, Austria, Belgium, Cyprus, Estonia, Finland,
France, Georgia, Greece, Hungary, Italy, Latvia, Malta,
Romania, the Slovak Republic, and Switzerland in chil-
dren aged 6–10, whereas Bulgaria (14.5%) [31], the
Czech Republic (14.7%) [31], Ireland (17.4%) [32], and
Norway (13.6%) [33] had markedly higher prevalence
rates.
In the UK, national studies of the prevalence of asthma
symptoms (wheezing) reported in 1986 that 6.6% of 16-
year-olds had wheezing in the past year [34] and by 1995
this had increased to 32.3% among 12–14 year old chil-
dren [15], using comparable questions. In the younger age
group (6–10 years) in the UK, the current prevalence of
wheezing ranged from 7.6% in 1980 [34] to 20.2% in
1999 [35], using comparable questions.
Studies in the Eastern Mediterranean and Africa
Apart from the ISAAC studies conducted in 1994–95, very
few countries had carried out epidemiological studies of
asthma in the Eastern Mediterranean and Africa, reported
in English (Additional File 3).
In Africa, very low prevalence rates were observed in Ethi-
opian rural communities (2.0% in 0–9 year olds, 1.7% in
10–19 year olds) [23], intermediate levels of wheeze prev-
alence (5%–14%) were observed in Algeria, Kenya,
Morocco and Nigeria and the highest rates were in South
Africa, 26.8% in 7–8 year olds in 1993 [36].
In the Eastern Mediterranean, Iran, Oman and Palestine
(West Bank) had the lowest prevalence of wheeze (<
11%), while the highest rates were observed in Israel
(17.9%) [37], Kuwait (16.1%) [38], and Malta (16.0%)
[15], amongst 13–14 year old adolescents. In Turkey,
many of the studies had not used the ISAAC question and
the prevalence of wheeze was low.
Studies in Asia
Amongst studies conducted in Asia, low prevalence rates
(< 9%) were observed in China, Hong Kong, India, Indo-
nesia and Malaysia while Japan (17.3%) [15], Korea
(13.6%) [39] and Singapore (15.7% in 1994 and 10.2%
in 2001) [15,40] had higher prevalence rates in 6–7 year
olds (Additional File 4). The majority of the studies
reported had used the ISAAC questions relating to current
wheeze.
Studies in Australasia
Australia, New Zealand and Fiji had a very high preva-
lence of current wheezing with the majority of the studies
showing the prevalence of current wheezing in the range
18% – 30% (Additional File 5). The highest prevalence of
30.2% was observed in New Zealand [15] amongst a very
large sample of 13–14 year olds in 1992–93, followed by
Australia [9] which observed a prevalence of 29.7%
amongst 12–15 year olds in 1991. Fiji [41] reported a
prevalence of 21.0% in 1990 amongst 9–10 year old chil-
dren.
Subgroup analysis: Studies in Australia and the UK
Australia and the UK had the largest number of studies
carried out and published (14 and 25 publications respec-
tively over the 16-year period), and these are investigated
further to assess differences in prevalence and trends in
prevalence between the two countries.Environmental Health 2008, 7:57 http://www.ehjournal.net/content/7/1/57
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The overall trend of the current wheeze prevalence, by cal-
endar year for both Australia and UK can be seen in Figure
1. This shows overall (over the period 1990–2005) an
increasing trend for both countries. Table 1 shows the
findings of multiple logistic regression analysis of the
effects of country (UK versus Australia), year of survey, age
of child, parental- or self-report questionnaire, and if the
study was an ISAAC study or not, on the current preva-
lence of wheeze. This allows each factor to be assessed
while adjusting for the other factors. When using the data
from all studies, Australia showed a statistically significant
increase in prevalence compared with the UK, OR = 1.343
[95% CI 1.318, 1.369] allowing for all other factors. There
was also a statistically significant increase in the preva-
lence per survey year (2.5% per year; 95% CI 2.3%, 2.6%),
and a significant decrease per year of age of child (0.7%
per year; 95% CI 0.3%, 1.1%). If the study was an ISAAC
study, phase I or III, then the odds of wheezing was signif-
icantly higher compared with non-ISAAC studies [OR =
1.638; 95% CI 1.598, 1.678], after adjusting for the other
factors. Similar results were obtained when comparing
ISAAC question with a non-ISAAC question (OR = 1.331;
95% CI 1.304, 1.359) after adjusting for all other factors.
When analysis was restricted to ISAAC studies there was a
statistically significant decrease in the prevalence per sur-
vey year (2.5% per year; 95% CI 2.1%, 2.9%), after allow-
ing for age of child and country (neither of which were
significant).
If the analysis is restricted to non-ISAAC studies, even if
the study had used the ISAAC question, then there was a
statistically significant increase in prevalence of wheezing
in Australia compared with the UK [OR = 1.470; 95% CI
1.438, 1.502], a significant increase in the prevalence per
survey year (2.6% per year; 95% CI 2.4%, 2.8%), a signif-
icant decrease in the prevalence per age of child (1.1% per
year; 95% CI 0.7%, 1.5%), and a significant increase in
wheezing if the questionnaire was self-report compared
with parental-report [OR = 1.242; 95% CI 1.197, 1.287].
This shows that the results of ISAAC studies are very differ-
ent from non-ISAAC studies.
The majority of studies carried out since ISAAC phase I,
have used the ISAAC question on wheezing, even if the
study was not a phase I or phase III ISAAC study. So the
analysis was then restricted only to studies which had
used the ISAAC question on wheezing. The results showed
that there was no significant difference in the prevalence
of wheezing between UK and Australia and age of child
was also not significant, after controlling for year of survey
and parental- or self-report questions. However there has
been a statistically significant decrease in the prevalence
per survey year (2.3% per year; 95% CI 1.9%, 2.7%) and
a significant increase in reported wheezing if the response
was self- compared with parental-report (OR = 1.739;
95% CI 1.624, 1.862).
As the rate of increase in the trends for wheezing preva-
lence over time looked different in UK and Australia (Fig-
ure 1), an extra interaction terms was fitted in the multiple
logistic regression model using all studies (Table 2). The
country by year interaction effect shows that Australia has
a significantly lower rate of increase in wheezing (6.2%
per calendar year; 95% CI 5.7%, 6.7%) compared with the
UK, after allowing for all other factors.
Discussion
In this review we have reported the prevalence of current
wheezing in children, published in all epidemiological
studies comprising more than 1000 persons and meeting
certain other quality criteria (see the Methods), over a 16-
year-period, between 1990 and 2005, and further investi-
gated the differences in reported symptoms of wheeze
between ISAAC and non-ISAAC studies, in the UK and
Australia.
Table 1: Multiple logistic regression analysis using all studies in the UK and Australia of country, year, area, age and type of study on 
the prevalence of wheeze
Variable All studies Odds Ratio 
(95% CI)(+p-value)
ISAAC studies only 
Odds Ratio (95% 
CI)(+p-value)
Non-ISAAC studies 
only Odds Ratio (95% 
CI)(+p-value)
ISAAC question only 
Odds Ratio (95% 
CI)(+p-value)
Country: UK (reference) vs 
Australia
1.343 [1.318, 1.369]
p < 0.0005
0.987 [0.958, 1.016]
p = 0.373
1.470 [1.438, 1.502]
p < 0.0005
0.986 [0.957, 1.017]
p = 0.370
Year of survey 1.025 [1.023, 1.026]
p < 0.0005
0.975 [0.971, 0.979]
p < 0.0005
1.026 [1.024, 1.028]
p < 0.0005
0.977 [0.973, 0.981]
p < 0.0005
Age of children surveyed 0.993 [0.989, 0.997]
p < 0.0005
1.007 [0.998, 1.016]
p = 0.124
0.989 [0.985, 0.993]
p < 0.0005
1.006 [0.995, 1.017]
p = 0.260
Parental- (reference) vs 
Self-response
1.290 [1.246, 1.335]
p < 0.0005
§
-
1.242 [1.197, 1.287]
p < 0.0005
1.739 [1.624, 1.862]
p < 0.0005
ISAAC study: No 
(reference) vs Yes
1.638 [1.598, 1.678]
p < 0.0005
- -
-
- -
-
- -
-
§OR not given as age of child (7–8 & 13–14 yrs) in ISAAC is parent-report & self-report respectivelyEnvironmental Health 2008, 7:57 http://www.ehjournal.net/content/7/1/57
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Overall, the highest prevalence rates of current wheezing
were reported in the UK, Australia and New Zealand, and
the lowest prevalence was found in Albania, China, Ethi-
opia, Indonesia and Turkey, which gives an indication of
the difference between developed and developing coun-
tries. The pattern in Africa and Asia also supports this.
However, this is not supported in America, where Chile,
Costa Rica and Peru had equally high wheezing preva-
lence as the US and Canada. Chile and Costa Rica are rel-
atively developed countries, that may have similar
characteristics in relation to development of wheezing in
childhood as fully developed countries such as the US and
Canada. However, this apparent inconsistency (in rela-
tion to Peru) requires further research.
Within the UK there was slightly higher prevalence of
wheezing in adolescents in Scotland compared with Eng-
land but there were no other substantial geographic varia-
tions, suggesting no major impact of climate, diet or
outdoor environment [42]. Also, prevalence of wheezing
was lower in children born outside the UK but currently
residing in the UK, suggesting a role of the environment
in infancy and possibly heritable genetic factors [42,43].
However, although genetic factors are important risk fac-
Prevalence of "wheezing in the last year" by calendar year of survey in all children (aged 0–16), reported in published studies in  Australia and UK Figure 1
Prevalence of "wheezing in the last year" by calendar year of survey in all children (aged 0–16), reported in 
published studies in Australia and UK.
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Table 2: Multiple logistic regression analysis using all studies in UK and Australia, as for Table 1, with interaction term (country × 
year)
Variable Odds Ratio (95% CI) p-value
Country [UK (reference) versus Australia] 1.406 [1.379, 1.433] p < 0.0005
Year of survey 1.032 [1.030, 1.034] p < 0.0005
Age of children surveyed 0.993 [0.989, 0.997] p = 0.016
Parental-response (reference) vs Self-complete 1.239 [1.197, 1.283] p < 0.0005
ISAAC study [No (reference) versus Yes]  1.649 [1.609, 1.690] p < 0.0005
Country by Year interaction 0.938 [0.933, 0.943] p < 0.0005Environmental Health 2008, 7:57 http://www.ehjournal.net/content/7/1/57
Page 7 of 10
(page number not for citation purposes)
tors for individuals with symptoms of asthma, migrant
studies indicate that they are unlikely to be responsible for
the large variations in asthma symptoms that exist
between populations, and cannot be responsible for the
increasing prevalence of asthma within populations [44].
Environmental factors are likely to be more important
and offer the greatest opportunities for prevention.
The cross-sectional ISAAC phase I study, carried out in
1994–1995, was a major achievement, and repeated in
2002–2003, the phase III study [15,16]. However, the
selected ISAAC centres were most commonly an urban
area (a city) and therefore may not be representative of the
country. This is illustrated, for example, in Brazil where in
the ISAAC phase I centres, which were all major cities, the
prevalence of current wheezing in 6–7 year olds was
higher than in non-ISAAC centres, which were iron-min-
ing cities and mountainous regions (23% vs 14% respec-
tively). The ISAAC studies also have the disadvantage of
reporting wheezing symptoms only amongst two age
groups (6–7 yr and 13–14 yr), and at only 2 time points
(phase I and III), whereas this review shows the results of
all studies of all age groups.
This review has shown that differing rates of asthma
symptoms are observed in developed and developing
countries. The validity of the question on wheezing in the
questionnaire is likely to have varied across cultures as
some languages do not have an equivalent word for
"wheezing" as understood by English speakers. However,
large variations in the prevalence of wheezing across the
countries and over time, found in these studies are
unlikely to be explained by methodological factors alone.
When making comparisons of the prevalence of wheeze
or asthma between different studies, it is necessary to crit-
ically assess the content of the question. There is, as yet,
no accepted definition of asthma and identification of
asthma by questionnaire remains a contentious issue
[45]. One question is whether the everyday meaning of
the word wheezing has changed over time. Do better edu-
cated parents use this word more freely for symptoms in
their children? The threshold of observing mild respira-
tory symptoms could be lower now than previously and
health campaigns may have increased parental awareness
of symptoms in their children. Another interesting
hypothesis is the loss of protective effect of respiratory
infection in early childhood, the "hygiene hypothesis"
[46]. This confirms the importance of the ISAAC phase II
data collection, which was completed in 2003, and in
which objective measures of pulmonary function and
bronchial responsiveness are recorded in conjunction
with other factors, so that further study of possible aetio-
logical factors common to different countries can be
investigated.
Australia and the UK had the most published studies on
wheezing prevalence in children and were investigated in
much more detail (Tables 1, 2). In addition, in these
countries the ISAAC studies reported significantly higher
wheezing prevalence than non-ISAAC studies and this was
not due to an increase over time, nor age of child, both of
which (and various other variables) were adjusted for in
the analyses. It is possible that this is due to the selection
of the ISAAC centres, which were all major cities. There are
various possible explanations for the differences in cur-
rent prevalence of wheezing including susceptibility to
environmental stimuli and changes in exposure to envi-
ronmental factors, genetic susceptibility, diet, low birth
weight and young maternal age [47-52].
Using all the studies in UK and Australia, we find that
there was a significantly higher odds of wheezing in Aus-
tralia than the UK, but the rate of increase in Australia is
significantly lower than the UK, as shown by the highly
significant interaction between country and year. The
multiple logistic regression analysis we performed for the
prevalence of wheezing adjusted for age, time period, type
of study (ISAAC vs non-ISAAC) and type of response
(parental or self report) and does not appear therefore to
result from methodological bias (e.g., confounding by
ISAAC status). These differences indicate some significant
discrepancy in early life environment between the two
countries over the last 20 or so years.
If only ISAAC studies are investigated then there was no
difference in prevalence between the two countries, after
adjusting for time and age of the child, whereas non-
ISAAC studies show significantly higher odds of wheezing
in Australia. This is very likely because the ISAAC studies
in these countries were carried out at two similar time
points and for two age groups. The non-ISAAC studies
span a much larger time period, use a wider range of ages
and include many more study groups, and in particular
are not restricted to large conurbations.
If time trends are explored in all studies in the UK and
Australia, then overall there is a significant increase in the
odds of wheezing over time, but only ISAAC studies show
a significant decrease, which was also reported in the
recent results of the phase I in 1995 and phase III in 2002,
ISAAC study comparisons [16]. This is almost certainly a
result of the different time periods covered by these two
sorts of survey. The ISAAC studies cover the period from
the early 1990s onwards, whereas other studies tend to
cover earlier years, some as early as 1975. This is consist-
ent with the trend of wheezing prevalence increasing since
the 1970's but levelling out in the most recent 10–15
years, as shown in Figure 1. This is also confirmed in other
reports; evidence from many repeat surveys shows that the
prevalence has increased over the past 3 decades [53], butEnvironmental Health 2008, 7:57 http://www.ehjournal.net/content/7/1/57
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in studies between 1991 to 1998 the increase was con-
fined to minor symptoms of asthma [54].
A decrease in reported symptoms of wheezing, as the child
gets older, was observed in the UK and Australia, which
confirms previous reports [55]. In ISAAC studies the age
effect is not significant, perhaps because only two age
groups were studied. Self-report of wheezing was signifi-
cantly higher than parental-report, in the UK and Aus-
tralia, again confirming previous work [56].
The ISAAC questionnaire has become almost ubiquitous
since the early 1990's and we have shown that using an
ISAAC question or the results of the ISAAC studies give
similar results within Australia and the UK.
Wheeze may indicate undiagnosed asthma in some
patients. Some studies have shown that self-reported
wheeze has reasonably good specificity and sensitivity for
bronchial hyper-responsiveness both in children and
adults [3-5]. Wheeze is rarely a symptom of emphysema
or chronic bronchitis in children, but it is very often indic-
ative of acute viral infection, which is common in this age
group [6]. Doctor-diagnosed asthma tends to be reported
in only a small proportion (about 40%) of persons report-
ing wheeze [57], so that the possibility of selection or
information bias in studies of asthma or wheeze cannot
be discounted in general.
Conclusion
In summary, the strength of this review is the reporting of
the prevalence of all studies of more than 1000 persons,
providing a full description of the scale and distribution
of asthma symptoms (wheeze in the past year), world-
wide and over time within each country. Among the coun-
tries surveyed, the UK has the highest recorded prevalence
of wheezing and Ethiopia the lowest. We have docu-
mented a clear increase in the prevalence over time within
Australia and the UK, with a levelling off or even decline
in prevalence in more recent years. ISAAC studies show
higher prevalence rates of wheezing than non-ISAAC stud-
ies.
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